author-photo

Paul LaRosee

University of Jena

6

Papers

59

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

SAFETY AND CLINICAL ACTIVITY OF TEMSIROLIMUS IN COMBINATION WITH RITUXIMAB AND DHAP IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA-REPORT OF THE PROSPECTIVE, MULTICENTER PHASE II STORM TRIAL

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial

2016 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

2014 Blood
Show All
- Source
- Cite
- Save
Citations (33)
Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on An Ongoing Phase I/II Trial

2011 Blood
Show All
- Source
- Cite
- Save
Citations (17)